The John Ochsner Heart and Vascular Institute is the first in Louisiana to offer an AI-powered treatment for atrial fibrillation.
The software, created by Volta, provides physicians with real-time analysis of 3D heart maps during catheter ablation procedures and detects irregular electrogram patterns, according to a Sept. 18 news release from Ochsner Health.
According to Michael Bernard, MD, section head of electrophysiology at Ochsner Health, the use of Volta’s AI resulted in high disease-free rates during randomized clinical trials.
More than 6 million people in the U.S. have Afib, and it is projected that more than 12 million people in the U.S. will be affected by Afib by 2030, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.